ARAna C Rocha

Ana C Rocha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana C Rocha has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Andrea Dias

    Serviço de Cuidados Intensivos Pediátricos. Hospital Pediátrico. Unidade Local de Saúde de Coimbra. Coimbra; Clínica Universitária de Pediatria. Faculdade de Medicina. Universidade de Coimbra. Coimbra

    1 shared publication
  • Carla Pinto

    Serviço de Cuidados Intensivos Pediátricos. Hospital Pediátrico de Coimbra. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal

    1 shared publication
  • Guiomar Oliveira

    Unidade de Neurodesenvolvimento e Autismo, Serviço do Centro de Desenvolvimento da Criança, Centro de Investigação e Formação Clínica, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra (CHUC), 3000-602 Coimbra, Portugal

    1 shared publication
  • Joana Verdelho Andrade

    Centro Hospitalar Tondela-Viseu E.P.E.

    1 shared publication
  • Joana de Brito Chagas

    Pediatric Department Hospital Pediátrico, Centro Hospitalar Universitário de Coimbra (HP‐CHUC) Coimbra Portugal

    1 shared publication
  • Leonor Carvalho

    Pediatric Intensive Care Unit Hospital Pediátrico (HP‐CHUC) Coimbra Portugal

    1 shared publication

Latest Publications

  • Open Access

    The prognostic value of delta‐lactate in critically ill children

    by Ana C Rocha, Joana B Chagas, Joana V Andrade, Carla Pinto, Guiomar Oliveira, Andrea S Dias, Leonor Carvalho

    AimThis study aimed to test delta-lactate (Delta L) as a short-term risk stratification method in critically ill children. MethodsAn exploratory study of patients admitted to paediatric intensive care unit (PICU) was conducted. Delta L was calculated as the difference between the maximum lactate concentrations on Days 1 and 2. According to the Delta L cutoff, two groups were considered: low mortality risk (LMR) - Delta L >= 0.05 mmol/L - and high mortality risk (HMR) - Delta L < 0.05 mmol/L. ResultsMortality, both during PICU stay and at 28 days, was statistically associated with elevated serum lactate on D1 and D2, per se. For the 93 cases with elevated lactate on Day 1, and a Delta L cutoff of 0.05 mmol/L, the area under the ROC curve was 0.698 (95% confidence interval, 0.47-0.93). HMR patients scored higher PIM3, were not discharged home until 28 days, counted fewer ventilation-free days and needed renal replacement therapy more often. ConclusionElevated lactate levels at admission, as well as applying the optimal cutoff for Delta L, allowed to predict short-term mortality: if an increase or minimal decrease in lactate maximum levels occurred from D1 to D2, death was almost eight times more probable. In critically ill children, delta-lactate predicts short-term outcome.